Showing results (11-20 of 497) with videos related to
Sort By:
Pageof 50
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Management of acute hepatitis B and reactivation of hepatitis BAnkur Jindal, Manoj Kumar, Shiv K SarinInternational Journal of Rheumatic Diseases|July 11, 2023
An update on understanding the pathophysiology in Kawasaki disease: Possible role of immune complexes in coronary artery lesion revisitedSaji Philip, Ankur Jindal, Raman Krishna KumarExpert Review of Gastroenterology & Hepatology|November 2, 2016
Reviewing the diagnostic criteria for acute-on-chronic liver failureAnkur Jindal, Archana Rastogi, Shiv Kumar SarinCardiorenal Medicine|February 6, 2013
Obesity and the Cardiorenal Metabolic Syndrome: Therapeutic Modalities and Their Efficacy in Improving Cardiovascular and Renal Risk FactorsAnkur Jindal, Stephen Brietzke, James R SowersJournal of Clinical and Experimental Hepatology|May 10, 2022
Hepatic Regeneration in CirrhosisAnkur Jindal, Rakesh K Jagdish, Anupam KumarJournal of Radiology Case Reports|November 27, 2014
Angiosarcoma of the liver: imaging of a rare salient entityShalini Thapar, Archana Rastogi, Arvind Ahuja, et al.Indian Journal of Experimental Biology|August 10, 2013
Anti-depressant like activity of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (6o) a 5-HT3 receptor antagonistShvetank Bhatt, Radhakrishnan Mahesh, Thangaraj Devadoss, et al.Current Cardiovascular Risk Reports|May 14, 2013
Type 2 diabetes in older people; the importance of blood pressure controlAnkur Jindal, Adam Whaley-Connell, James R SowersPharmacology, Biochemistry, and Behavior|April 29, 2014
Protective effects of a novel 5-HT3 receptor antagonist, N-n-butyl-3-methoxy quinoxaline-2-carboxamide (6o) against chronic unpredictable mild stress-induced behavioral changes and biochemical alterationsShvetank Bhatt, Radhakrishnan Mahesh, Ankur Jindal, et al.Indian Journal of Experimental Biology|August 1, 2013
Anxiolytic-like effect of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (60) in experimental mouse models of anxietyShvetank Bhatt, Radhakrishnan Mahesh, Thangaraj Devadoss, et al.Pageof 50